Post-Bariatric Hypoglycemia in Individuals with Obesity and Type 2 Diabetes after Laparoscopic Roux-en-Y Gastric Bypass: A Prospective Cohort Study.
Dimitrios KehagiasCharalampos LampropoulosSotirios-Spyridon VamvakasEirini KehagiaNeoklis GeorgopoulosIoannis KehagiasPublished in: Biomedicines (2024)
Post-bariatric hypoglycemia (PBH) is an increasingly recognized complication after metabolic bariatric surgery (MBS). The aim of this study is to investigate potential factors associated with PBH. A cohort of 24 patients with type 2 diabetes mellitus (T2DM) and body mass index (BMI) ≥40 kg/m 2 who underwent laparoscopic Roux-en-Y gastric bypass (LRYGBP) was retrospectively investigated for PBH at 12 months. PBH was defined as postprandial glucose at 120 min below 60 mg/dL. Questionnaires based on the Edinburgh hypoglycemia scale were filled out by the participants. Glycemic parameters and gastrointestinal (GI) hormones were also investigated. Based on the questionnaires, five patients presented more than four symptoms that were highly indicative of PBH at 12 months. According to glucose values at 120 min, one patient experienced PBH at 6 months and four patients experienced it at 12 months. Postprandial insulin values at 30 min and 6 months seem to be a strong predictor for PBH ( p < 0.001). GLP-1 and glucagon values were not significantly associated with PBH. PBH can affect patients with T2DM after MBS, reaching the edge of hypoglycemia. Postprandial insulin levels at 30 min and 6 months might predict the occurrence of PBH at 12 months, but this requires further validation with a larger sample size.
Keyphrases
- type diabetes
- roux en y gastric bypass
- weight loss
- glycemic control
- end stage renal disease
- body mass index
- bariatric surgery
- newly diagnosed
- ejection fraction
- blood glucose
- gastric bypass
- prognostic factors
- chronic kidney disease
- insulin resistance
- peritoneal dialysis
- cardiovascular disease
- blood pressure
- metabolic syndrome
- physical activity
- risk assessment
- adipose tissue
- mass spectrometry
- case report
- skeletal muscle
- patient reported outcomes
- minimally invasive